Welcome to LookChem.com Sign In|Join Free
  • or
Indazole-1,5-dicarboxylic acid 1-tert-butyl ester 5-Methyl ester is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1290181-22-4

Post Buying Request

1290181-22-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1290181-22-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1290181-22-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,9,0,1,8 and 1 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1290181-22:
(9*1)+(8*2)+(7*9)+(6*0)+(5*1)+(4*8)+(3*1)+(2*2)+(1*2)=134
134 % 10 = 4
So 1290181-22-4 is a valid CAS Registry Number.

1290181-22-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-O-tert-butyl 5-O-methyl indazole-1,5-dicarboxylate

1.2 Other means of identification

Product number -
Other names 1-tert-Butyl 5-methyl 1H-indazole-1,5-dicarboxylate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1290181-22-4 SDS

1290181-22-4Downstream Products

1290181-22-4Relevant academic research and scientific papers

Imidazole-containing condensed tricyclic compound and application thereof

-

Paragraph 0320, (2018/03/01)

The invention discloses an imidazole-containing condensed tricyclic compound adopting the structure as shown in the formula (I) or pharmaceutically acceptable salts, stereisomers or prodrug molecules thereof. The imidazole-containing condensed tricyclic compound has the IDO1 activity regulation function, can enhance T-cell activation through blocking immune checkpoints IDO1, is used for treating IDO1-mediated immunosuppression, and therefore, can become an effective medicine for treating malignant tumors. When used together with checkpoint protein anti-body drugs or other anti-cancer drugs, the imidazole-containing condensed tricyclic compound can enhance the anti-cancer effect. Meanwhile, the imidazole-containing condensed tricyclic compound has the potential of effectively treating IDO1 abnormity related immunosuppressive diseases and has a high application value.

PYRAZOLOPYRIDINE DERIVATIVES AS ANTICANCER AGENT

-

Page/Page column 75, (2011/05/05)

The present invention concerns compounds of following general formula (I): (Formula I) and their pharmaceutically acceptable salts, their method of preparation and their uses, notably as anticancer agent.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1290181-22-4